This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Godson, C. Articles by Reppert, S. M. Search for Related Content PubMed PubMed Citation Articles by Godson, C. Articles by Reppert, S. M.

The Mel_1a Melatonin Receptor Is Coupled to Parallel Signal Transduction Pathways¹

Laboratory of Developmental Chronobiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114

Address all correspondence and requests for reprints to: Dr. Catherine Godson, Laboratory of Developmental Chronobiology, Jackson 1226, Massachusetts General Hospital, Boston, Massachusetts 02114. E-mail: godson{at}helix.mgh.harvard.edu

The recent cloning of a family of high affinity melatonin receptors has provided us with a unique opportunity to define the signal transduction pathways used by these receptors. We have studied signaling through the human Mel_1a receptor subtype by stable expression of receptor complementary DNA in NIH 3T3 cells. Our data indicate that the human Mel_1a receptor is coupled to inhibition of forskolin-stimulated cAMP accumulation by a pertussis toxin-sensitive G protein. Although melatonin alone is without effect on phosphoinositide hydrolysis, it potentiates the effects of PGF₂ stimulation on phospholipase C activation. Melatonin potentiates arachidonate release stimulated by PGF₂ and by ionomycin. The effects of melatonin on arachidonate release are sensitive to inhibition of protein kinase C. They are independent of the effects of melatonin on cAMP and do not appear to involve activation of mitogen-activated protein kinase. The effects of melatonin on both phosphoinositide hydrolysis and arachidonate release are sensitive to pertussis toxin treatment. Thus, we show that the melatonin signal is transduced by parallel pathways involving inhibition of adenylyl cyclase and potentiation of phospholipase activation.

This article has been cited by other articles:

				V. Srinivasan, D W. Spence, S. R. Pandi-Perumal, I. Trakht, and D. P. Cardinali Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms Integr Cancer Ther, September 1, 2008; 7(3): 189 - 203. [Abstract] [PDF]

				D. Lanoix, R. Ouellette, and C. Vaillancourt Expression of melatoninergic receptors in human placental choriocarcinoma cell lines Hum. Reprod., August 1, 2006; 21(8): 1981 - 1989. [Abstract] [Full Text] [PDF]

				F. Steffens, X.-B. Zhou, U. Sausbier, C. Sailer, K. Motejlek, P. Ruth, J. Olcese, M. Korth, and T. Wieland Melatonin Receptor Signaling in Pregnant and Nonpregnant Rat Uterine Myocytes as Probed by Large Conductance Ca2+-Activated K+ Channel Activity Mol. Endocrinol., October 1, 2003; 17(10): 2103 - 2115. [Abstract] [Full Text] [PDF]

				M. J. Gerdin, M. I. Masana, D. Ren, R. J. Miller, and M. L. Dubocovich Short-Term Exposure to Melatonin Differentially Affects the Functional Sensitivity and Trafficking of the hMT1 and hMT2 Melatonin Receptors J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 931 - 939. [Abstract] [Full Text] [PDF]

				D. Roy and D. D. Belsham Melatonin Receptor Activation Regulates GnRH Gene Expression and Secretion in GT1-7 GnRH Neurons. SIGNAL TRANSDUCTION MECHANISMS J. Biol. Chem., January 4, 2002; 277(1): 251 - 258. [Abstract] [Full Text]

				M. I. Masana and M. L. Dubocovich Melatonin Receptor Signaling: Finding the Path Through the Dark Sci. Signal., November 6, 2001; 2001(107): pe39 - pe39. [Abstract] [Full Text] [PDF]

				L. Brydon, L. Petit, P. Delagrange, A. D. Strosberg, and R. Jockers Functional Expression of MT2 (Mel1b) Melatonin Receptors in Human PAZ6 Adipocytes Endocrinology, October 1, 2001; 142(10): 4264 - 4271. [Abstract] [Full Text] [PDF]

				F. Zalatan, J. A. Krause, and D. E. Blask Inhibition of Isoproterenol-Induced Lipolysis in Rat Inguinal Adipocytes in Vitro by Physiological Melatonin via a Receptor-Mediated Mechanism Endocrinology, September 1, 2001; 142(9): 3783 - 3790. [Abstract] [Full Text] [PDF]

				C. S. Nelson, M. Ikeda, H. S. Gompf, M. L. Robinson, N. K. Fuchs, T. Yoshioka, K. A. Neve, and C. N. Allen Regulation of Melatonin 1a Receptor Signaling and Trafficking by Asparagine-124 Mol. Endocrinol., August 1, 2001; 15(8): 1306 - 1317. [Abstract] [Full Text] [PDF]

				D. G. Hazlerigg, P. J. Morgan, and S. Messager Decoding Photoperiodic Time and Melatonin in Mammals: What Can We Learn from the Pars Tuberalis? J Biol Rhythms, August 1, 2001; 16(4): 326 - 335. [Abstract] [PDF]

				A. E. Hunt, W. M. Al-Ghoul, M. U. Gillette, and M. L. Dubocovich Activation of MT2 melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock Am J Physiol Cell Physiol, January 1, 2001; 280(1): C110 - C118. [Abstract] [Full Text] [PDF]

				L. Brydon, F. Roka, L. Petit, P. de Coppet, M. Tissot, P. Barrett, P. J. Morgan, C. Nanoff, A. D. Strosberg, and R. Jockers Dual Signaling of Human Mel1a Melatonin Receptors via Gi2, Gi3, and Gq/11 Proteins Mol. Endocrinol., December 1, 1999; 13(12): 2025 - 2038. [Abstract] [Full Text]

				F. Roka, L. Brydon, M. Waldhoer, A. D. Strosberg, M. Freissmuth, R. Jockers, and C. Nanoff Tight Association of the Human Mel1a-Melatonin Receptor and Gi: Precoupling and Constitutive Activity Mol. Pharmacol., November 1, 1999; 56(5): 1014 - 1024. [Abstract] [Full Text]

				S. Benloucif, M. I. Masana, K. Yun, and M. L. Dubocovich Interactions between Light and Melatonin on the Circadian Clock of Mice J Biol Rhythms, August 1, 1999; 14(4): 281 - 289. [Abstract] [PDF]

				A. GARCÍA RATO, J. GARCÍA PEDRERO, M. A. MARTÍNEZ, B. DEL RIO, P. S. LAZO, and S. RAMOS Melatonin blocks the activation of estrogen receptor for DNA binding FASEB J, May 1, 1999; 13(8): 857 - 868. [Abstract] [Full Text]

				M. D. A. Kopp, C. Schomerus, F. Dehghani, H.-W. Korf, and H. Meissl Pituitary Adenylate Cyclase-Activating Polypeptide and Melatonin in the Suprachiasmatic Nucleus: Effects on the Calcium Signal Transduction Cascade J. Neurosci., January 1, 1999; 19(1): 206 - 219. [Abstract] [Full Text] [PDF]

				F. B. Lima, U. F. Machado, I. Bartol, P. M. Seraphim, D. H. Sumida, S. M. F. Moraes, N. S. Hell, M. M. Okamoto, M. J. A. Saad, C. R. O. Carvalho, et al. Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E934 - E941. [Abstract] [Full Text] [PDF]

				P. A. Witt-Enderby, M. I. Masana, and M. L. Dubocovich Physiological Exposure to Melatonin Supersensitizes the Cyclic Adenosine 3',5'-Monophosphate-Dependent Signal Transduction Cascade in Chinese Hamster Ovary Cells Expressing the Human mt1 Melatonin Receptor Endocrinology, July 1, 1998; 139(7): 3064 - 3071. [Abstract] [Full Text] [PDF]

				J. VANECEK Cellular Mechanisms of Melatonin Action Physiol Rev, July 1, 1998; 78(3): 687 - 721. [Abstract] [Full Text] [PDF]

				A. W. Ross, C. A. Webster, M. Thompson, P. Barrett, and P. J. Morgan A Novel Interaction Between Inhibitory Melatonin Receptors and Protein Kinase C-Dependent Signal Transduction in Ovine Pars Tuberalis Cells Endocrinology, April 1, 1998; 139(4): 1723 - 1730. [Abstract] [Full Text] [PDF]

				E. Gilad, H. Matzkin, and N. Zisapel Inactivation of Melatonin Receptors by Protein Kinase C in Human Prostate Epithelial Cells Endocrinology, October 1, 1997; 138(10): 4255 - 4261. [Abstract] [Full Text] [PDF]

				B. McMahon, C. Stenson, F. McPhillips, A. Fanning, H. R. Brady, and C. Godson Lipoxin A4 Antagonizes the Mitogenic Effects of Leukotriene D4 in Human Renal Mesangial Cells. DIFFERENTIAL ACTIVATION OF MAP KINASES THROUGH DISTINCT RECEPTORS J. Biol. Chem., September 1, 2000; 275(36): 27566 - 27575. [Abstract] [Full Text] [PDF]